Some brighter views
21/06/22 -"We have revised our models and included all figures. We have become more optimistic about Kabi’s profitability (IV drug’s brake to earnings sorted) and allowed for Helios’ higher than anticipated ..."
Pages
57
Language
English
Published on
21/06/22
You may also be interested by these reports :
28/06/22
Philips shared the results of tests conducted on a sample of sleep apnea devices from the US and Canada, wherein the majority of the devices passed ...
28/06/22
Following the availability of the formal annual report, we have integrated the audited FY21 actual figures which were consistent with the preliminary ...
21/06/22
We have revised our models and included all figures. We have become more optimistic about Kabi’s profitability (IV drug’s brake to earnings sorted) ...
21/06/22
With the double-whammy of waning pandemic-driven opportunities and the markets becoming increasingly-wary of high P/E MedTechs, testing stocks are ...